Notice Information
Notice Title
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Notice Description
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
Lot Information
Lot 1 - Low and High Strength Albumin
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Offer reference number: CM/PHS/23/5703
Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Offer reference number: CM/PHS/23/5703
Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Offer reference number: CM/PHS/23/5703
Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Offer reference number: CM/PHS/23/5703
Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Offer reference number: CM/PHS/23/5703
Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Offer reference number: CM/PHS/23/5703
Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-048730
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/001899-2025
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33651520 - Immunoglobulins
Notice Value(s)
- Tender Value
- £1,700,000,000 £1B-£10B
- Lots Value
- £5 Under £100K
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 20 Jan 20251 years ago
- Submission Deadline
- 13 Sep 2024Expired
- Future Notice Date
- Not specified
- Award Date
- 19 Dec 20241 years ago
- Contract Period
- 31 Mar 2025 - 31 Dec 2027 2-3 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Contact Name
- Michelle Clarke
- Contact Email
- michelle.clarke6@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- LEEDS
- Postcode
- LS1 4AP
- Post Town
- Leeds
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- Not specified
-
- Local Authority
- Leeds
- Electoral Ward
- Hunslet & Riverside
- Westminster Constituency
- Leeds South
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-048730-2025-01-20T15:25:25Z",
"date": "2025-01-20T15:25:25Z",
"ocid": "ocds-h6vhtk-048730",
"description": "Out of the awarded suppliers, they were either awarded a committed market share or designated as reserve status with no committed market share. Further information on committed or reserve status by Lot is shown below:<br/><br/>Lot 1<br/>Awarded Supplier - CSL, Grifols<br/>Reserve Supplier - Octapharma<br/><br/>Lot 2<br/>Awarded Supplier - Octapharma<br/>Reserve Supplier - Grifols, Takeda<br/><br/>Lot 3<br/>Awarded Supplier - Grifols, Octapharma, Takeda<br/>Reserve Supplier - BPL, CSL, LFB<br/><br/>Lot 4<br/>Awarded Supplier - Grifols, Octapharma, Takeda<br/>Reserve Supplier - CSL<br/><br/>Lot 5<br/>Awarded Supplier - Takeda<br/>Reserve Supplier - N/A<br/><br/>Lot 6 <br/>Awarded Supplier - CSL<br/>Reserve Supplier - BPL",
"initiationType": "tender",
"tender": {
"id": "CM/PHS/23/5703",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
},
"mainProcurementCategory": "goods",
"description": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.",
"value": {
"amount": 1700000000,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"title": "Lot 1 - Low and High Strength Albumin",
"description": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2025-04-01T00:00:00+01:00",
"endDate": "2027-12-31T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "2",
"title": "Lot 2 - 5% Intravenous Immunoglobulin",
"description": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2025-04-01T00:00:00+01:00",
"endDate": "2027-12-31T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "3",
"title": "Lot 3 - 10% Intravenous Immunoglobulin",
"description": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2025-04-01T00:00:00+01:00",
"endDate": "2027-12-31T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "4",
"title": "Lot 4 - Subcutaneous Immunoglobulin",
"description": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.",
"contractPeriod": {
"startDate": "2025-04-01T00:00:00+01:00",
"endDate": "2027-12-31T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "5",
"title": "Lot 5 - Facilitated Subcutaneous Immunoglobulin",
"description": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2025-04-01T00:00:00+01:00",
"endDate": "2027-12-31T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "6",
"title": "Lot 6 - Anti-D Immunoglobulin",
"description": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2025-04-01T00:00:00+01:00",
"endDate": "2027-12-31T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists participating authorities"
},
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists participating authorities"
},
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists participating authorities"
},
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists participating authorities"
},
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists participating authorities"
},
"relatedLot": "5"
},
{
"id": "6",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists participating authorities"
},
"relatedLot": "6"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://health-family.force.com/s/Welcome",
"communication": {
"atypicalToolUrl": "https://health-family.force.com/s/Welcome"
},
"documents": [
{
"id": "economic",
"documentType": "economicSelectionCriteria"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"techniques": {
"hasFrameworkAgreement": true
},
"tenderPeriod": {
"endDate": "2024-09-13T13:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 180
}
},
"awardPeriod": {
"startDate": "2024-09-13T13:00:00+01:00"
},
"bidOpening": {
"date": "2024-09-13T13:00:00+01:00",
"address": {
"streetAddress": "Runcorn"
},
"description": "MPSC employee"
},
"hasRecurrence": false,
"contractTerms": {
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed",
"hasElectronicPayment": true
}
},
"parties": [
{
"id": "GB-FTS-118033",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "7&8 Wellington Place",
"locality": "Leeds",
"region": "UKE",
"postalCode": "LS1 4AP",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Michelle Clarke",
"email": "michelle.clarke6@nhs.net",
"url": "https://health-family.force.com/s/Welcome"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk//",
"buyerProfile": "https://www.england.nhs.uk//",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-1661",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "The Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
}
},
{
"id": "GB-FTS-107961",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "7-8 Wellington Place",
"locality": "Leeds",
"region": "UK",
"postalCode": "LS1 4AP",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Michelle Clarke",
"email": "michelle.clarke6@nhs.net"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-135540",
"name": "CSL BEHRING UK LIMITED",
"identifier": {
"legalName": "CSL BEHRING UK LIMITED",
"id": "01622483"
},
"address": {
"streetAddress": "4 Milton Road Haywards Heath West Sussex",
"locality": "Haywards Heath",
"region": "UK",
"postalCode": "RH16 1AH",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "http://www.cslbehring.co.uk",
"scale": "large"
}
},
{
"id": "GB-FTS-135541",
"name": "Grifols UK (Diagnostics)",
"identifier": {
"legalName": "Grifols UK (Diagnostics)",
"id": "01456099"
},
"address": {
"streetAddress": "6th Floor One London Wall, London, EC2Y 5EB",
"locality": "LONDON",
"region": "UK",
"postalCode": "EC2Y 5EB",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-135542",
"name": "Octapharma Limited",
"identifier": {
"legalName": "Octapharma Limited",
"id": "02372699"
},
"address": {
"streetAddress": "Octapharma Ltd, 32 Shudehill, Manchester, M4 1EZ",
"locality": "Manchester",
"region": "UK",
"postalCode": "M4 1EZ",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "http://www.octapharma.co.uk",
"scale": "sme"
}
},
{
"id": "GB-FTS-135543",
"name": "Takeda UK Limited",
"identifier": {
"legalName": "Takeda UK Limited",
"id": "03362860"
},
"address": {
"streetAddress": "1 Kingdom Street",
"locality": "LONDON",
"region": "UK",
"postalCode": "W2 6BD",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "contracts.uk@takeda.com"
},
"roles": [
"supplier"
],
"details": {
"url": "http://www.takeda.co.uk",
"scale": "large"
}
},
{
"id": "GB-FTS-132779",
"name": "BIO PRODUCTS LABORATORY LIMITED",
"identifier": {
"legalName": "BIO PRODUCTS LABORATORY LIMITED",
"id": "07343036"
},
"address": {
"streetAddress": "C/O Bio Products Laboratory, Dagger Lane, Elstree, Hertfordshire, WD6 3BX",
"locality": "Elstree",
"region": "UK",
"postalCode": "WD6 3BX",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "http://www.bpl.co.uk",
"scale": "large"
}
},
{
"id": "GB-FTS-135544",
"name": "LFB BIOMEDICAMENTS",
"identifier": {
"legalName": "LFB BIOMEDICAMENTS",
"id": "491371167"
},
"address": {
"streetAddress": "3 AVENUE DES TROPIQUES 91940 LES ULIS FRANCE",
"locality": "Les Ulis",
"region": "FR",
"postalCode": "91958",
"countryName": "France"
},
"contactPoint": {
"telephone": "+33 169827010"
},
"roles": [
"supplier"
],
"details": {
"url": "https://www.groupe-lfb.com/",
"scale": "large"
}
},
{
"id": "GB-FTS-135545",
"name": "BIO PRODUCTS LABORATORY LIMITED",
"identifier": {
"legalName": "BIO PRODUCTS LABORATORY LIMITED",
"id": "07343036"
},
"address": {
"streetAddress": "C/O Bio Products Laboratory, Dagger Lane, Elstree, Hertfordshire, WD6 3BX",
"locality": "ELSTREEE",
"region": "UK",
"postalCode": "WD6 3BX",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "http://www.bpl.co.uk",
"scale": "large"
}
}
],
"buyer": {
"id": "GB-FTS-107961",
"name": "NHS England"
},
"language": "en",
"awards": [
{
"id": "001899-2025-1",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135540",
"name": "CSL BEHRING UK LIMITED"
}
]
},
{
"id": "001899-2025-2",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135541",
"name": "Grifols UK (Diagnostics)"
}
]
},
{
"id": "001899-2025-3",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135542",
"name": "Octapharma Limited"
}
]
},
{
"id": "001899-2025-4",
"relatedLots": [
"2"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135543",
"name": "Takeda UK Limited"
}
]
},
{
"id": "001899-2025-5",
"relatedLots": [
"2"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135541",
"name": "Grifols UK (Diagnostics)"
}
]
},
{
"id": "001899-2025-6",
"relatedLots": [
"2"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135542",
"name": "Octapharma Limited"
}
]
},
{
"id": "001899-2025-7",
"relatedLots": [
"3"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135540",
"name": "CSL BEHRING UK LIMITED"
}
]
},
{
"id": "001899-2025-8",
"relatedLots": [
"3"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-132779",
"name": "BIO PRODUCTS LABORATORY LIMITED"
}
]
},
{
"id": "001899-2025-9",
"relatedLots": [
"3"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135543",
"name": "Takeda UK Limited"
}
]
},
{
"id": "001899-2025-10",
"relatedLots": [
"3"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135541",
"name": "Grifols UK (Diagnostics)"
}
]
},
{
"id": "001899-2025-11",
"relatedLots": [
"3"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135542",
"name": "Octapharma Limited"
}
]
},
{
"id": "001899-2025-12",
"relatedLots": [
"3"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135544",
"name": "LFB BIOMEDICAMENTS"
}
]
},
{
"id": "001899-2025-13",
"relatedLots": [
"4"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135540",
"name": "CSL BEHRING UK LIMITED"
}
]
},
{
"id": "001899-2025-14",
"relatedLots": [
"4"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135543",
"name": "Takeda UK Limited"
}
]
},
{
"id": "001899-2025-15",
"relatedLots": [
"4"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135541",
"name": "Grifols UK (Diagnostics)"
}
]
},
{
"id": "001899-2025-16",
"relatedLots": [
"4"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135542",
"name": "Octapharma Limited"
}
]
},
{
"id": "001899-2025-17",
"relatedLots": [
"5"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135543",
"name": "Takeda UK Limited"
}
]
},
{
"id": "001899-2025-18",
"relatedLots": [
"6"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135540",
"name": "CSL BEHRING UK LIMITED"
}
]
},
{
"id": "001899-2025-19",
"relatedLots": [
"6"
],
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-135545",
"name": "BIO PRODUCTS LABORATORY LIMITED"
}
]
}
],
"contracts": [
{
"id": "001899-2025-1",
"awardID": "001899-2025-1",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-2",
"awardID": "001899-2025-2",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-3",
"awardID": "001899-2025-3",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-4",
"awardID": "001899-2025-4",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-5",
"awardID": "001899-2025-5",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-6",
"awardID": "001899-2025-6",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-7",
"awardID": "001899-2025-7",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-8",
"awardID": "001899-2025-8",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-9",
"awardID": "001899-2025-9",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-10",
"awardID": "001899-2025-10",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-11",
"awardID": "001899-2025-11",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-12",
"awardID": "001899-2025-12",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-13",
"awardID": "001899-2025-13",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-14",
"awardID": "001899-2025-14",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-15",
"awardID": "001899-2025-15",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-16",
"awardID": "001899-2025-16",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-17",
"awardID": "001899-2025-17",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-18",
"awardID": "001899-2025-18",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
},
{
"id": "001899-2025-19",
"awardID": "001899-2025-19",
"title": "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2024-12-19T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"value": 6
},
{
"id": "4",
"measure": "bids",
"value": 6
},
{
"id": "7",
"measure": "bids",
"value": 6
},
{
"id": "10",
"measure": "bids",
"relatedLot": "2",
"value": 6
},
{
"id": "13",
"measure": "bids",
"relatedLot": "2",
"value": 6
},
{
"id": "16",
"measure": "bids",
"relatedLot": "2",
"value": 6
},
{
"id": "19",
"measure": "bids",
"relatedLot": "3",
"value": 6
},
{
"id": "22",
"measure": "bids",
"relatedLot": "3",
"value": 6
},
{
"id": "25",
"measure": "bids",
"relatedLot": "3",
"value": 6
},
{
"id": "28",
"measure": "bids",
"relatedLot": "3",
"value": 6
},
{
"id": "31",
"measure": "bids",
"relatedLot": "3",
"value": 6
},
{
"id": "34",
"measure": "bids",
"relatedLot": "3",
"value": 6
},
{
"id": "37",
"measure": "bids",
"relatedLot": "4",
"value": 6
},
{
"id": "40",
"measure": "bids",
"relatedLot": "4",
"value": 6
},
{
"id": "43",
"measure": "bids",
"relatedLot": "4",
"value": 6
},
{
"id": "46",
"measure": "bids",
"relatedLot": "4",
"value": 6
},
{
"id": "49",
"measure": "bids",
"relatedLot": "5",
"value": 6
},
{
"id": "52",
"measure": "bids",
"relatedLot": "6",
"value": 6
},
{
"id": "55",
"measure": "bids",
"relatedLot": "6",
"value": 6
},
{
"id": "2",
"measure": "smeBids",
"value": 0
},
{
"id": "5",
"measure": "smeBids",
"value": 0
},
{
"id": "8",
"measure": "smeBids",
"value": 0
},
{
"id": "11",
"measure": "smeBids",
"relatedLot": "2",
"value": 0
},
{
"id": "14",
"measure": "smeBids",
"relatedLot": "2",
"value": 0
},
{
"id": "17",
"measure": "smeBids",
"relatedLot": "2",
"value": 0
},
{
"id": "20",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "23",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "26",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "29",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "32",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "35",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "38",
"measure": "smeBids",
"relatedLot": "4",
"value": 0
},
{
"id": "41",
"measure": "smeBids",
"relatedLot": "4",
"value": 0
},
{
"id": "44",
"measure": "smeBids",
"relatedLot": "4",
"value": 0
},
{
"id": "47",
"measure": "smeBids",
"relatedLot": "4",
"value": 0
},
{
"id": "50",
"measure": "smeBids",
"relatedLot": "5",
"value": 0
},
{
"id": "53",
"measure": "smeBids",
"relatedLot": "6",
"value": 0
},
{
"id": "56",
"measure": "smeBids",
"relatedLot": "6",
"value": 0
},
{
"id": "3",
"measure": "electronicBids",
"value": 6
},
{
"id": "6",
"measure": "electronicBids",
"value": 6
},
{
"id": "9",
"measure": "electronicBids",
"value": 6
},
{
"id": "12",
"measure": "electronicBids",
"relatedLot": "2",
"value": 6
},
{
"id": "15",
"measure": "electronicBids",
"relatedLot": "2",
"value": 6
},
{
"id": "18",
"measure": "electronicBids",
"relatedLot": "2",
"value": 6
},
{
"id": "21",
"measure": "electronicBids",
"relatedLot": "3",
"value": 6
},
{
"id": "24",
"measure": "electronicBids",
"relatedLot": "3",
"value": 6
},
{
"id": "27",
"measure": "electronicBids",
"relatedLot": "3",
"value": 6
},
{
"id": "30",
"measure": "electronicBids",
"relatedLot": "3",
"value": 6
},
{
"id": "33",
"measure": "electronicBids",
"relatedLot": "3",
"value": 6
},
{
"id": "36",
"measure": "electronicBids",
"relatedLot": "3",
"value": 6
},
{
"id": "39",
"measure": "electronicBids",
"relatedLot": "4",
"value": 6
},
{
"id": "42",
"measure": "electronicBids",
"relatedLot": "4",
"value": 6
},
{
"id": "45",
"measure": "electronicBids",
"relatedLot": "4",
"value": 6
},
{
"id": "48",
"measure": "electronicBids",
"relatedLot": "4",
"value": 6
},
{
"id": "51",
"measure": "electronicBids",
"relatedLot": "5",
"value": 6
},
{
"id": "54",
"measure": "electronicBids",
"relatedLot": "6",
"value": 6
},
{
"id": "57",
"measure": "electronicBids",
"relatedLot": "6",
"value": 6
}
]
}
}